Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07109713 · ClinicalTrials.gov registry record · NA
The Effect Cranberry-Based Products on the Female Microbiome
A NA study of Gut Microbiome and Gut Health, sponsored by Ocean Spray Cranberries.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07109713: Recruiting NA study of Gut Microbiome and Gut Health, sponsored by Ocean Spray Cranberries.
NCT07109713 is a NA study of Gut Microbiome and Gut Health that is actively recruiting participants, run by Ocean Spray Cranberries. The registered enrollment target is 60 participants, below the 265-participant average among 22 other Gut Microbiome trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07109713, a NA study of Gut Microbiome and Gut Health, is actively recruiting participants, sponsored by Ocean Spray Cranberries.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of this clinical trial is to compare the effects of a cranberry-based product to a placebo-control product on vaginal and GI microbiome outcomes and associated participant reported outcomes in generally healthy pre-menopausal women
Primary Outcome
The number of participants exhibiting a Lactobacillus-dominant CST vaginal microbiome following the 28-day intervention
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Active
Study Locations (1)
Illinois
- Biofortis - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-08-05 |
| Est. Completion | 2025-12-20 |
| Phase | NA |
What NCT07109713 shows while recruiting
NCT07109713 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 265-participant average among 22 other Gut Microbiome trials with a reported enrollment target (77% lower).
The record links to 3 conditions, with Gut Microbiome appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07109713 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07109713 about?
NCT07109713 is a clinical study titled "The Effect Cranberry-Based Products on the Female Microbiome". The overall objective of this clinical trial is to compare the effects of a cranberry-based product to a placebo-control product on vaginal and GI microbiome outcomes and associated participant reported outcomes in generally healthy pre-menopausal women
What is the current status of trial NCT07109713?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-08-05. Estimated completion is 2025-12-20.
What conditions does trial NCT07109713 study?
This clinical trial studies the following conditions: Gut Microbiome, Gut Health, Vaginal Microbiome.
What interventions are being tested in trial NCT07109713?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Active (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07109713?
This trial is sponsored by Ocean Spray Cranberries, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07109713 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gut Microbiome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07109713's enrollment target sits among peer trials
60 10th of 22 higher than 11 of 22 other Gut Microbiome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gut Microbiome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Flourish: Exploring the Early Infant Gut Microbiome
RECRUITING · NA
-
The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study
RECRUITING · NA
-
Enhanced Nutritional Optimization in LVAD Trial
RECRUITING · NA
-
Feasibility and Potential Efficacy of Herbs and Spices for Improving Dietary Quality in College Students: A Pilot Study
RECRUITING · NA
-
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
RECRUITING · NA
-
Effects of Mango or Low-Fat Cookie Consumption on Gut Health, and Its Relationship With Mental, Sexual and Skin Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI